The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Infantile Spasms Therapeutics-Global Market Insights and Sales Trends 2025
Synopsis
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global Infantile Spasms Therapeutics market size is expected to reach US$ 182.4 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Infantile Spasms Therapeutics in various end use industries. The expanding demands from the Hospital, Clinic and Other, are propelling Infantile Spasms Therapeutics market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
Global Infantile Spasms Therapeutics key players include Mallinckrodt, H. Lundbeck, etc. Global top two manufacturers hold a share over 60%.
In terms of product, Oral is the largest segment, with a share obout 55%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infantile Spasms Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infantile Spasms Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infantile Spasms Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infantile Spasms Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infantile Spasms Therapeutics covered in this report include Mallinckrodt, H. Lundbeck, Insys Therapeutics, Orphelia Pharma, Valerion Therapeutics, Catalyst Pharmaceuticals, Anavex Life Sciences, Retrophin and GW Pharmaceuticals, etc.
The global Infantile Spasms Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals
Global Infantile Spasms Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infantile Spasms Therapeutics market, Segment by Type:
Oral
Injection
Global Infantile Spasms Therapeutics market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infantile Spasms Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global Infantile Spasms Therapeutics market size is expected to reach US$ 182.4 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Infantile Spasms Therapeutics in various end use industries. The expanding demands from the Hospital, Clinic and Other, are propelling Infantile Spasms Therapeutics market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
Global Infantile Spasms Therapeutics key players include Mallinckrodt, H. Lundbeck, etc. Global top two manufacturers hold a share over 60%.
In terms of product, Oral is the largest segment, with a share obout 55%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infantile Spasms Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infantile Spasms Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infantile Spasms Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infantile Spasms Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infantile Spasms Therapeutics covered in this report include Mallinckrodt, H. Lundbeck, Insys Therapeutics, Orphelia Pharma, Valerion Therapeutics, Catalyst Pharmaceuticals, Anavex Life Sciences, Retrophin and GW Pharmaceuticals, etc.
The global Infantile Spasms Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals
Global Infantile Spasms Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infantile Spasms Therapeutics market, Segment by Type:
Oral
Injection
Global Infantile Spasms Therapeutics market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infantile Spasms Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Infantile Spasms Therapeutics
1.1 Infantile Spasms Therapeutics Market Overview
1.1.1 Infantile Spasms Therapeutics Product Scope
1.1.2 Infantile Spasms Therapeutics Market Status and Outlook
1.2 Global Infantile Spasms Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Infantile Spasms Therapeutics Market Size by Region (2018-2029)
1.4 Global Infantile Spasms Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Infantile Spasms Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Infantile Spasms Therapeutics Market Size (2018-2029)
1.6.1 North America Infantile Spasms Therapeutics Market Size (2018-2029)
1.6.2 Europe Infantile Spasms Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Infantile Spasms Therapeutics Market Size (2018-2029)
1.6.4 Latin America Infantile Spasms Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Infantile Spasms Therapeutics Market Size (2018-2029)
2 Infantile Spasms Therapeutics Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Injection
2.2 Global Infantile Spasms Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Infantile Spasms Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Infantile Spasms Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Infantile Spasms Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Infantile Spasms Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Infantile Spasms Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Infantile Spasms Therapeutics Revenue Breakdown by Type (2018-2029)
3 Infantile Spasms Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Other
3.2 Global Infantile Spasms Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Infantile Spasms Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Infantile Spasms Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Infantile Spasms Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Infantile Spasms Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Infantile Spasms Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Infantile Spasms Therapeutics Revenue Breakdown by Application (2018-2029)
4 Infantile Spasms Therapeutics Competition Analysis by Players
4.1 Global Infantile Spasms Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infantile Spasms Therapeutics as of 2022)
4.3 Date of Key Players Enter into Infantile Spasms Therapeutics Market
4.4 Global Top Players Infantile Spasms Therapeutics Headquarters and Area Served
4.5 Key Players Infantile Spasms Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Infantile Spasms Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Mallinckrodt
5.1.1 Mallinckrodt Profile
5.1.2 Mallinckrodt Main Business
5.1.3 Mallinckrodt Infantile Spasms Therapeutics Products, Services and Solutions
5.1.4 Mallinckrodt Infantile Spasms Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Mallinckrodt Recent Developments
5.2 H. Lundbeck
5.2.1 H. Lundbeck Profile
5.2.2 H. Lundbeck Main Business
5.2.3 H. Lundbeck Infantile Spasms Therapeutics Products, Services and Solutions
5.2.4 H. Lundbeck Infantile Spasms Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 H. Lundbeck Recent Developments
5.3 Insys Therapeutics
5.3.1 Insys Therapeutics Profile
5.3.2 Insys Therapeutics Main Business
5.3.3 Insys Therapeutics Infantile Spasms Therapeutics Products, Services and Solutions
5.3.4 Insys Therapeutics Infantile Spasms Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Orphelia Pharma Recent Developments
5.4 Orphelia Pharma
5.4.1 Orphelia Pharma Profile
5.4.2 Orphelia Pharma Main Business
5.4.3 Orphelia Pharma Infantile Spasms Therapeutics Products, Services and Solutions
5.4.4 Orphelia Pharma Infantile Spasms Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Orphelia Pharma Recent Developments
5.5 Valerion Therapeutics
5.5.1 Valerion Therapeutics Profile
5.5.2 Valerion Therapeutics Main Business
5.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Products, Services and Solutions
5.5.4 Valerion Therapeutics Infantile Spasms Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Valerion Therapeutics Recent Developments
5.6 Catalyst Pharmaceuticals
5.6.1 Catalyst Pharmaceuticals Profile
5.6.2 Catalyst Pharmaceuticals Main Business
5.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Products, Services and Solutions
5.6.4 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Catalyst Pharmaceuticals Recent Developments
5.7 Anavex Life Sciences
5.7.1 Anavex Life Sciences Profile
5.7.2 Anavex Life Sciences Main Business
5.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Products, Services and Solutions
5.7.4 Anavex Life Sciences Infantile Spasms Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Anavex Life Sciences Recent Developments
5.8 Retrophin
5.8.1 Retrophin Profile
5.8.2 Retrophin Main Business
5.8.3 Retrophin Infantile Spasms Therapeutics Products, Services and Solutions
5.8.4 Retrophin Infantile Spasms Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Retrophin Recent Developments
5.9 GW Pharmaceuticals
5.9.1 GW Pharmaceuticals Profile
5.9.2 GW Pharmaceuticals Main Business
5.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Products, Services and Solutions
5.9.4 GW Pharmaceuticals Infantile Spasms Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 GW Pharmaceuticals Recent Developments
6 North America
6.1 North America Infantile Spasms Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Infantile Spasms Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Infantile Spasms Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Infantile Spasms Therapeutics Market Dynamics
11.1 Infantile Spasms Therapeutics Industry Trends
11.2 Infantile Spasms Therapeutics Market Drivers
11.3 Infantile Spasms Therapeutics Market Challenges
11.4 Infantile Spasms Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
